A new immune structure found in liver tumors could improve treatment for liver cancer patients. These structures are linked ...

Liver biochemistry (usually normal in cases of benign, uncomplicated tumors), viral serologies, and tumor markers are useful for excluding liver disease or with atypical presentations. The ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...

Liver cancer is a significant global health issue, and its early detection plays a crucial role in improving patient outcomes ...

Liver Cancer: Molecular Signaling Pathway of Tumor Development Decoded Apr. 23, 2024 — As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of ...

Immune checkpoint inhibitor tumor regression may indicate which patients with hepatocellular carcinoma experience improved ...

Over 800 thousand people are diagnosed with liver cancer every year worldwide, and it accounts for more than 700 thousand ...

Traditional liver tumor treatments include surgery, chemo, and radiation. Now, doctors have a new tool in their toolbox to ...

Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis ...

you need a combination therapy to target the tumor and to target the immune system,” he adds. “This is a strategy to be able ...